Launch new institute for regenerative medicine
On 30 March, RegMed XB, a new cooperation for regenerative medicine was launched in the Leiden University Medical Centre (LUMC). The initiative for RegMed XB was taken by Maastricht University professor Clemens van Blitterswijk (MERLN).
Regenerative medicine aims to heal patients by restoring tissues and organs. This means that diseased tissue and organs can be restored, making transplants no longer necessary. The research of RegMed XB consists of three research tracks, focusing on kidney failure, diabetes type 1 and arthrosis. Researchers of Maastricht University, the LUMC, Utrecht University and the Eindhoven University of Technology collaborate in these research tracks. In Belgium the University of Leuven and the Flemish Institute for Biotechnology participate. Also several companies of the Brightlands Health Campus are affiliated with RegMed XB.
For more information about RegMed XB, see this press release.
Photo gallery
Photography: Arno Massee